FDA Drug Application (022013) for OLUX E by DELCOR ASSET

Back to FDA Applications sponsored by DELCOR ASSET

Application Number022013
Product Number001
FormAEROSOL, FOAM;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLUX E
Active IngredientCLOBETASOL PROPIONATE



Back to FDA Applications sponsored by DELCOR ASSET

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.